In conclusion, we recommend identifying the BCR-ABL transcript type in every CML patient at diagnosis along with the cytogenetic study, using a reliably reproducible and empirically verified method. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.